참고문헌
- Timmer-Bosscha, H., Mulder, N.H., de Vries, E.G. Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br J Cancer 66: 227-238, 1992 https://doi.org/10.1038/bjc.1992.249
- Goldstein, R.S., Mayor, G.H. Minireview. The nephrotoxicity of cisplatin. Life Sci 32: 685-690, 1983 https://doi.org/10.1016/0024-3205(83)90299-0
- Safirstein, R., Winston, J., Goldstein, M., Moel, D., Dikman, S., Guttenplan, J. Cisplatin nephrotoxicity. Am J Kidney Dis 8: 356-367, 1986 https://doi.org/10.1016/S0272-6386(86)80111-1
- Eastman, A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther 34: 155-166, 1987 https://doi.org/10.1016/0163-7258(87)90009-X
- Siddik, Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279, 2003 https://doi.org/10.1038/sj.onc.1206933
- Cross, T.G., Scheel-Toellner, D., Henriquez, N.V., Deacon, E., Salmon, M., Lord, J.M. Serine/threonine protein kinases and apoptosis. Exp Cell Res 256: 34-41, 2000 https://doi.org/10.1006/excr.2000.4836
- Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.E., Karandikar, M., Berman, K., Cobb, M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183, 2001 https://doi.org/10.1210/er.22.2.153
- Bedi, A., Barber, J.P., Bedi, G.C., el-Deiry, W.S., Sidransky, D., Vala, M.S., Akhtar, A.J., Hilton, J., Jones, R.J. BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood 86: 1148-1158, 1995
- Latif, C., Harvey, S.H., O'Connell, M.J. Ensuring the stability of the genome: DNA damage checkpoints. ScientificWorldJournal 1: 684-702, 2001 https://doi.org/10.1100/tsw.2001.297
- Schwartz, D., Almog, N., Peled, A., Goldfinger, N., Rotter, V. Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repair. Oncogene 15: 2597-2607, 1997 https://doi.org/10.1038/sj.onc.1201436
- Tomasevic, G., Kamme, F., Stubberod, P., Wieloch, M., Wieloch, T. The tumor suppressor p53 and its response gene p21WAF1/Cip1 are not markers of neuronal death following transient global cerebral ischemia. Neuroscience 90: 781-792, 1999 https://doi.org/10.1016/S0306-4522(98)00484-9
- in, Z., Lim, S., Viani, M.A., Sapp, M., Lim, M.S. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. Am J Pathol 159: 711-719, 2001 https://doi.org/10.1016/S0002-9440(10)61742-7
- Miyaji, T., Kato, A., Yasuda, H., Fujigaki, Y., Hishida, A. Role of the increase in p21 in cisplatin-induced acute renal failure in rats. J Am Soc Nephrol 12: 900-908, 2001
- Shankland, S.J., Wolf, G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 278: F515-529, 2000 https://doi.org/10.1152/ajprenal.2000.278.4.F515
- Sherr, C.J., Roberts, J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999 https://doi.org/10.1101/gad.13.12.1501
- Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B., Craig, R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 56: 892-898, 1996
- Harris, C.C. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442-1455, 1996 https://doi.org/10.1093/jnci/88.20.1442
- Stewart, N., Hicks, G.G., Paraskevas, F., Mowat, M. Evidence for a second cell cycle block at G2/M by p53. Oncogene 10: 109-115, 1995
- garwal, M.L., Agarwal, A., Taylor, W.R., Stark, G.R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92: 8493-8497, 1995
- Cobb, M.H. MAP kinase pathways. Prog Biophys Mol Biol 71: 479-500, 1999 https://doi.org/10.1016/S0079-6107(98)00056-X
- Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., Greenberg, M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995 https://doi.org/10.1126/science.270.5240.1326
- Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252, 2000 https://doi.org/10.1016/S0092-8674(00)00116-1
- Lee, S.J., Saiki, I., Hayakawa, Y., Nunome, S., Yamada, H., Kim, S.H. Antimetastatic and immunomodulating properties of a new herbal prescription, Bojung-bangamtang. Int Immunopharmacol 3: 147-157, 2000 https://doi.org/10.1016/S1567-5769(02)00091-7
- Kim, N.S., Ju, S.M., Kwon, Y.D., Shin, B.C., Ahn, K.S., Kim, S.H., Song, Y.S., Jeon, B.H. Anti-apoptotic effect of bojungbangam-tang ethanol extract on cisplatin-induced apoptosis in rat mesnagial cells. J Orient Physiol Pathol 20: 1664-1671, 2006
- Kwon, K.B., Kim, E.K., Lee, Y.R., Ju, S.M., Ryu, D.G., Kim, S.H., Jeon, B.H. Protective effects of sanyakbojungbangam-tang ethanol extracts on cisplatin-induced apoptosis in ECV304 cells. J Orient Physiol Pathol 20: 20-24, 2006
- Lee, E.O., Shim, B.S., Surh, Y.J., Jeon, B..H, Ahn, K.S., Kim, S.H. Study on the anti-angiogenic activity of ethanol extract of bojungbangam-tang. J Orient Physiol Pathol 20: 15-19, 2006
- Orren, D.K., Petersen, L.N., Bohr, V.A. Persistent DNA damage inhibits S-phase and G2 progression, and results in apoptosis. Mol Biol Cell 8: 1129-1142, 1997 https://doi.org/10.1091/mbc.8.6.1129
- Fujimoto, K., Hosotani, R., Doi, R., Wada, M., Lee, J.U., Koshiba, T., Miyamoto, Y., Tsuji, S., Nakajima, S., Imamura, M. Induction of cell-cycle arrest and apoptosis by a novel retinobenzoic-acid derivative, TAC-101, in human pancreatic-cancer cells. Int J Cancer 81: 637-644, 1999 https://doi.org/10.1002/(SICI)1097-0215(19990517)81:4<637::AID-IJC21>3.0.CO;2-4
- Gamet-Payrastre, L., Li, P., Lumeau, S., Cassar, G., Dupont, M.A., Chevolleau, S., Gasc, N., Tulliez, J., Terce, F. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 60: 1426-1433, 2000
- O'Connor, P.M., Ferris, D.K., Pagano, M., Draetta, G., Pines, J., Hunter, T., Longo, D.L., Kohn, K.W. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J Biol Chem 268: 8298-8308, 1993
- Murray, A.W. Recycling the cell cycle: cyclins revisited. Cell 116: 221-234, 2004 https://doi.org/10.1016/S0092-8674(03)01080-8
- Covacci, V., Bruzzese, N., Sgambato, A., Di Francesco, A., Russo, M.A., Wolf, F.I., Cittadini, A. Magnesium restriction induces granulocytic differentiation and expression of p27Kip1 in human leukemic HL-60 cells. J Cell Biochem 70: 313-322, 1998 https://doi.org/10.1002/(SICI)1097-4644(19980901)70:3<313::AID-JCB4>3.0.CO;2-Q
- Sherr, C.J. Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995 https://doi.org/10.1101/gad.9.10.1149
- Peter, M. Herskowitz I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79: 233-244, 1994 https://doi.org/10.1016/0092-8674(94)90193-7
- Elledge, S.J. Harper, J.W. Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol 6: 847-852, 1994 https://doi.org/10.1016/0955-0674(94)90055-8
- Brugarolas, J., Chandrasekaran, C., Gordon, J.I., Beach, D., Jacks, T., Hannon, G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557, 1995 https://doi.org/10.1038/377552a0
- Owa, T., Yoshino, H., Yoshimatsu, K., Nagasu, T. Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem 8: 1487-1503, 2001 https://doi.org/10.2174/0929867013371996
- el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993 https://doi.org/10.1016/0092-8674(93)90500-P
- He, G., Siddik, Z.H., Huang, Z., Wang, R., Koomen, J., Kobayashi, R., Khokhar, A.R., Kuang, J. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 24: 2929-2943, 2005 https://doi.org/10.1038/sj.onc.1208474
- Igata, M., Motoshima, H., Tsuruzoe, K., Kojima, K., Matsumura, T., Kondo, T., Taguchi, T., Nakamaru, K., Yano, M., Kukidome, D., Matsumoto, K., Toyonaga, T., Asano, T., Nishikawa, T., Araki, E. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ Res 97: 837-844, 2005 https://doi.org/10.1161/01.RES.0000185823.73556.06
- right, J.W., Stouffer, R.L., Rodland, K.D. High-dose estrogen and clinical selective estrogen receptor modulators induce growth arrest, p21, and p53 in primate ovarian surface epithelial cells. J Clin Endocrinol Metab 90: 3688-3695, 2005 https://doi.org/10.1210/jc.2004-2456
- Cummings, B.S., Schnellmann, R.G. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 302: 8-17, 2002 https://doi.org/10.1124/jpet.302.1.8
- Jiang, M., Yi, X., Hsu, S., Wang, C.Y., Dong, Z. Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity. Am J Physiol Renal Physiol 287: F1140-1147, 2004 https://doi.org/10.1152/ajprenal.00262.2004
- Baliga, R., Ueda, N., Walker, P.D., Shah, S.V. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 31: 971-997, 1999 https://doi.org/10.1081/DMR-100101947
- Nath, K.A., Norby, S.M. Reactive oxygen species and acute renal failure. Am J Med 109: 665-678, 2000 https://doi.org/10.1016/S0002-9343(00)00612-4
- Martindale, J.L., Holbrook, N.J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1-15, 2002 https://doi.org/10.1002/jcp.10119
- Takahashi, Y., Ogra, Y., Suzuki, K.T. Synchronized generation of reactive oxygen species with the cell cycle. Life Sci 75: 301-311, 2004 https://doi.org/10.1016/j.lfs.2003.12.014
- Helt, C.E., Rancourt, R.C., Staversky, R.J., O'Reilly, M.A. p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity. Toxicol Sci 63: 214-222, 2001 https://doi.org/10.1093/toxsci/63.2.214
- 권승봉. 원색임상본초학. 영림사, 1992
- Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., Greenberg, M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995 https://doi.org/10.1126/science.270.5240.1326
- Klekotka, P.A., Santoro, S.A., Wang, H., Zutter, M.M. Specific residues within the alpha 2 integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways. J Biol Chem 276: 32353-32361, 2001 https://doi.org/10.1074/jbc.M101921200
- Roulston, A., Reinhard, C., Amiri, P., Williams, L.T. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 273: 10232-10239, 1998 https://doi.org/10.1074/jbc.273.17.10232
- Nagata, Y., Todokoro, K. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94: 853-863, 1999
- Guadagno, T.M., Ferrell, J.E. Jr. Requirement for MAPK activation for normal mitotic progression in Xenopus egg extracts. Science 282: 1312-1315, 1998 https://doi.org/10.1126/science.282.5392.1312
- Wright, J.H., Munar, E., Jameson, D.R., Andreassen, P.R., Margolis, R.L., Seger, R., Krebs, E.G. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci USA 96: 11335-11340, 1999
- Bulavin, D.V., Higashimoto, Y., Popoff, I.J., Gaarde, W.A., Basrur, V., Potapova, O., Appella, E., Fornace, A.J. Jr. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411: 102-107, 2001 https://doi.org/10.1038/35075107
- Wang, X., McGowan, C.H., Zhao, M., He, L., Downey, J.S., Fearns, C., Wang, Y., Huang, S., Han, J. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol 20: 4543-4552, 2000 https://doi.org/10.1128/MCB.20.13.4543-4552.2000
- Bulavin, D.V., Higashimoto, Y., Popoff, I.J., Gaarde, W.A., Basrur, V., Potapova, O., Appella, E., Fornace, A.J. Jr. Initiation of a G2/M checkpoin after ultraviolet radiation requires p38 kinase. Nature 411: 102-107, 2001 https://doi.org/10.1038/35075107
- Wang, X., McGowan, C.H., Zhao, M., He, L., Downey, J.S., Fearns, C., Wang, Y., Huang, S., Han, J. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol 20: 4543-4552, 2000 https://doi.org/10.1128/MCB.20.13.4543-4552.2000
- Huang, C., Ma, W.Y., Maxiner, A., Sun, Y., Dong, Z. p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J Biol Chem 274: 12229-12235, 1999 https://doi.org/10.1074/jbc.274.18.12229
- Takekawa, M., Adachi, M., Nakahata, A., Nakayama, I., Itoh, F., Tsukuda, H., Taya, Y., Imai, K. p53-inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J 19: 6517-6526, 2000 https://doi.org/10.1093/emboj/19.23.6517
- Sanchez-Prieto, R., Rojas, J.M., Taya, Y., Gutkind, J.S. A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res 60: 2464-2472, 2000
- DeHaan, R.D., Yazlovitskaya, E.M., Persons, D.L. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase. Cancer Chemother. Pharmacol 48: 383-388, 2001 https://doi.org/10.1007/s002800100318
- Hayakawa, J., Ohmichi, M., Kurachi, H., Ikegami, H., Kimura, A., Matsuoka, T., Jikihara, H., Mercola, D., Murata, Y. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J Biol Chem 274: 31648-31654, 1999 https://doi.org/10.1074/jbc.274.44.31648
- Persons, D.L., Yazlovitskaya, E.M., Pelling, J.C. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J Biol Chem 275: 35778-357785, 2000 https://doi.org/10.1074/jbc.M004267200